EMDB-65801:
Cryo-EM structure of SARS-CoV-2 WT 6p spike protein in complex with P5-1C8 IgG (1.5 IgG)
Method: single particle / : Lv NN, Yang RY

EMDB-65802:
Cryo-EM structure of SARS-CoV-2 WT 6p spike protein in complex with P5-1C8 IgG (1 IgG)
Method: single particle / : Lv NN, Yang RY

EMDB-65803:
Immune complex of P5-1C8 Fab binding the RBD of Omicron JN.1 6p spike protein
Method: single particle / : Lv NN, Yang RY

EMDB-65804:
Immune complex of P5-1C8 Fab binding the RBD of Omicron BA.1 6p spike protein (2 Fab)
Method: single particle / : Lv NN, Yang RY

EMDB-65805:
Immune complex of P5-1C8 Fab binding the RBD of Omicron BA.1 6p spike protein (1 Fab)
Method: single particle / : Lv NN, Yang RY

EMDB-65806:
Immune complex of P5-1C8 IgG binding the RBD of Omicron BA.1 6p spike protein
Method: single particle / : Lv NN, Yang RY

EMDB-65807:
Immune complex of P5-1C8 Fab binding the RBD of SARS-CoV-2 WT 6p spike protein
Method: single particle / : Lv NN, Yang RY

EMDB-65808:
Immune complex of P5-1C8 IgG binding the RBD of SARS-CoV-2 WT 6p spike protein
Method: single particle / : Lv NN, Yang RY

EMDB-63979:
RABV G binding with CTB011 Fab and CTB012 Fab
Method: single particle / : Cao L, Zhang C

PDB-9ua5: Structure viewer
RABV G binding with CTB011 Fab and CTB012 Fab
Method: single particle / : Cao L, Zhang C

EMDB-52336:
Docedameric RuvBL1/RuvBL2
Method: single particle / : Santo PE, Plisson-Chastang C

EMDB-52773:
LpDE from Escherichia coli
Method: single particle / : Siroy R, Fronzes R, Ieva R

EMDB-52777:
LpDE from Escherichia coli
Method: single particle / : Siroy R, Fronzes R, Ieva R

EMDB-52778:
LpDEM from Escherichia coli
Method: single particle / : Siroy R, Fronzes R, Ieva R

EMDB-52779:
LpDEM from Escherichia coli
Method: single particle / : Siroy R, Fronzes R, Ieva R

PDB-9i9z: Structure viewer
LpDE from Escherichia coli
Method: single particle / : Siroy R, Fronzes R, Ieva R

PDB-9ia0: Structure viewer
LpDE from Escherichia coli
Method: single particle / : Siroy R, Fronzes R, Ieva R

PDB-9ia2: Structure viewer
LpDEM from Escherichia coli
Method: single particle / : Siroy R, Fronzes R, Ieva R

PDB-9ia5: Structure viewer
LpDEM from Escherichia coli
Method: single particle / : Siroy R, Fronzes R, Ieva R

EMDB-67283:
C1 Symmetry of DNA tesseract
Method: single particle / : Shiu SCC

EMDB-67284:
Octahedral Symmetry of DNA Tesseract
Method: single particle / : Shiu SCC

EMDB-70867:
DDB1-CRBN with Ikaros(ZF2) and DEG-47: composite map and model submission
Method: single particle / : Rizvi Z, Lander GC

EMDB-38189:
P-hexon capsomer of the VZV C-Capsid
Method: single particle / : Nan W, Lei C, Xiangxi W

EMDB-70776:
DDB1-CRBN open NU refine map
Method: single particle / : Rizvi Z, Lander GC

EMDB-70777:
DDB1-CRBN open local refinement
Method: single particle / : Rizvi Z, Lander GC

EMDB-70778:
DDB1-CRBNopen with lenalidomide
Method: single particle / : Rizvi Z, Lander GC

EMDB-70781:
DDB1-CRBN intermediate NU
Method: single particle / : Rizvi Z, Lander GC

EMDB-70782:
DDB1-CRBN[Closed] with lenalidomide and SB-405483- consensus refinement
Method: single particle / : Rizvi Z, Lander GC

EMDB-70783:
DDB1-CRBN[Closed] with lenalidomide and SB-405483- Focused refine map
Method: single particle / : Rizvi Z, Lander GC

EMDB-70784:
Composite map of DDB1-CRBN[Closed] in the presence of Lenalidomide and SB-405483
Method: single particle / : Rizvi Z, Lander GC

EMDB-70788:
DDB1-CRBN-CK1a with lenalidomide and SB-405483
Method: single particle / : Rizvi Z, Lander GC

EMDB-70789:
DDB1-CRBN-CK1a with lenalidomide and SB-405483 (Focused map)
Method: single particle / : Rizvi Z, Lander GC

EMDB-70790:
DDB1-CRBN with casein kinase 1 alpha, lenalidomide, and SB-405483: composite map submission
Method: single particle / : Rizvi Z, Lander GC

EMDB-70795:
DDB1-CRBN with Ikaros ZF2-3, lenalidomide, and SB-405483: Consensus map
Method: single particle / : Rizvi Z, Lander GC

EMDB-70796:
DDB1-CRBN with Ikaros(ZF2-3), lenalidomide, and SB-405483: focused map submission
Method: single particle / : Rizvi Z, Lander GC

EMDB-70799:
DDB1-CRBN with Ikaros ZF2-3, lenalidomide, and SB-405483; composite map submission
Method: single particle / : Rizvi Z, Lander GC

EMDB-70801:
DDB1-CRBN with CK1a and DEG47
Method: single particle / : Rizvi Z, Lander GC

EMDB-70802:
DDB1-CRBN with CK1a and DEG-47: focused map on CRBN
Method: single particle / : Rizvi Z, Lander GC

EMDB-70803:
DDB1-CRBN with CK1A and DEG-47: Focused map on CK1a
Method: single particle / : Rizvi Z, Lander GC

EMDB-70804:
DDB1-CRBN with CK1a and DEG47: Composite map submission
Method: single particle / : Rizvi Z, Lander GC

EMDB-70827:
DDB1-CRBN with CK1a, SB-405483, and DEG-47- consensus map submission
Method: single particle / : Rizvi Z, Lander GC

EMDB-70835:
DDB1-CRBN with CK1a, SB-405483, and DEG-47: focused map on CRBN
Method: single particle / : Rizvi Z, Lander GC

EMDB-70836:
DDB1-CRBN with CK1 alpha, SB-405483, and DEG-47: Focused map on CK1 alpha
Method: single particle / : Rizvi Z, Lander GC

EMDB-70862:
DDB1-CRBN with CK1 alpha, SB-405483, and DEG-47: composite map and model submission
Method: single particle / : Rizvi Z, Lander GC

EMDB-70865:
DDB1-CRBN with ikaros(ZF2) and DEG47- consensus map submission
Method: single particle / : Rizvi Z, Lander GC

EMDB-70866:
DDB1-CRBN with Ikaros(ZF2) and DEG-47: focused map submission
Method: single particle / : Rizvi Z, Lander GC

EMDB-70868:
DDB1-CRBN with ikaros, SB-405483, and DEG-47: consensus map submission
Method: single particle / : Rizvi Z, Lander GC

EMDB-70869:
DDB1-CRBN with ikaros(ZF2) with SB-405483, and DEG-47: Focused map submission
Method: single particle / : Rizvi Z, Lander GC

EMDB-70870:
DDB1-CRBN with Ikaros(ZF2), SB-405483, and DEG-47: composite map and model submission
Method: single particle / : Rizvi Z, Lander GC

EMDB-52013:
Hexameric RuvBL1/RuvBL2 bound to SPAG1 C-ter
Method: single particle / : Santo PE, Plisson-Chastang C